Ankitkumar Patel
Interventional Cardiology · Glen Ridge, NJNPI 1184820557
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Heartflow, Inc. at 35.8% of the total. 2025 is the largest year on record at $203,776, more than ten times the $1,620 reported in 2019. Among interventional cardiology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 857 payments — averaging $475.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heartflow, Inc.$146K
- Medtronic$103K
- Abiomed$94K
- Cathworks, Inc.$18K
- Shockwave Medical, Inc$16K
- Edwards Lifesciences$11K
- plus $21K from 24 others
Across 36 payments — averaging $8624.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cathworks, Inc.$250K
- Saranas, Inc.$41K
- Abiomed$10K
- Genetesis, Inc.$9K
- ZOLL Circulation Inc$220
What the payments were for
- Consulting fees$91,19322%
- Speaking & faculty fees$186,59946%
- Travel & lodging$91,74922%
- Food & beverage$38,3169%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heartflow, Inc. | 71 | $145,946 |
| Medtronic(2 entities) | 327 | $102,858 |
| Abiomed | 227 | $93,538 |
| Cathworks, Inc. | 25 | $17,928 |
| Shockwave Medical, Inc | 29 | $16,085 |
| Edwards Lifesciences | 30 | $10,899 |
| Abbott | 52 | $10,116 |
| Penumbra, Inc. | 19 | $4,975 |
| Terumo Medical Corporation | 9 | $1,759 |
| Boston Scientific | 12 | $934 |
| Saranas, Inc. | 9 | $657 |
| Siemens Medical Solutions USA, Inc. | 4 | $423 |
| Novartis | 12 | $212 |
| Philips North America LLC | 5 | $207 |
| Cardiovascular Systems Inc. | 4 | $196 |
| Cvrx, Inc. | 2 | $196 |
| Amgen | 4 | $183 |
| Atricure, Inc. | 1 | $124 |
| Amarin Pharma, Inc. | 1 | $117 |
| Ancora Heart, Inc. | 1 | $103 |
| Angiodynamics, Inc. | 1 | $87 |
| Baxter Healthcare | 1 | $74 |
| Irhythm Technologies, Inc. | 3 | $63 |
| Neurocrine Biosciences, Inc. | 1 | $54 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $39 |
| Inari Medical, Inc. | 1 | $30 |
| Cardiva Medical, Inc. | 1 | $25 |
| Johnson & Johnson | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$145,342
- Impella$81,650
- FFRangio$51,002
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$15,824
- RESOLUTE ONYX$7,825
- SYMPLICITY G3$6,642
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$5,981
- DRAGONFLY OPSTAR$4,654
- Indigo System$4,602
- COROFLOW$3,577
- ONYX FRONTIER$3,199
- Resolute$1,853
- GLIDESHEATH SLENDER$1,725
- COREVALVE EVOLUT R$1,628
- SAPIEN 3 Ultra RESILIA$791
- XIENCE SIERRA$308
- CoreValve Evolut$270
- Watchman$249
- ARTIS icono biplane$229
- Barostim Neo System$186
How this compares
$407,874 in reported general payments places this provider in the 95th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 190 | $213,905 |
| EntrestoSacubitril/Valsartan | 71 | $100,489 |
| XareltoRivaroxaban | 35 | $46,758 |
| MultaqDronedarone Hcl | 32 | $33,341 |
| JardianceEmpagliflozin | 14 | $21,227 |
| Metoprolol Succinate | 387 | $5,214 |
| Atorvastatin Calcium | 358 | $4,180 |
| Rosuvastatin Calcium | 155 | $3,895 |
| Ranolazine ErRanolazine | 13 | $3,146 |
| Valsartan | 51 | $1,597 |
| ClopidogrelClopidogrel Bisulfate | 113 | $1,501 |
| Amlodipine Besylate | 190 | $1,352 |
| Losartan Potassium | 132 | $1,308 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 31 | $1,061 |
| Carvedilol | 64 | $1,019 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $212 | $100,48971 claims |
| Johnson & JohnsonXarelto | $16 | $46,75835 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 166 interventional cardiology providers in New Jersey.
Other interventional cardiology in Glen Ridge
- Ziad AbbudOcean$360K
- Ramin HastingsHasbrouck Heights$295K
- Michael LimHackensack$215K
- Darshan GodkarCedar Knolls$194K
- Ryan KapleHackensack$178K
- Matthew SayboltEatontown$175K
- Daniel KissEatontown$172K
- Kintur SanghviBordentown$139K
- Dimitrios KarmpaliotisMorristown$129K
- Sung-Han YoonHackensack$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.